if not SP comes down and does not go up easily - takes a lot of efforts to build the trust.
That's not true. Stock price can be manipulated beyond the companies control. Leo and co. have done a remarkable job at the science and especially, keeping us informed. I have much more trust in this company, rather than companies that keep everyone in the dark.
With a little more success with K like completion on phase one and peer reviewed articles going out, offers can arrive from many pharmaceutical companies.
The low cost to make K will add to the interest. The low toxicity of K and the orphan designations add value and interest also?
K can be very interesting. Big pharmas are big investors just like people on this board.
News 
Market Data 
Discover 
